Jacobs Levy Equity Management’s SolarWinds Corporation Common Stock SWI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-131,015
Closed -$1.58M 1079
2024
Q2
$1.58M Sell
131,015
-62,757
-32% -$725K 0.01% 647
2024
Q1
$2.45M Sell
193,772
-4,763
-2% -$58K 0.01% 560
2023
Q4
$2.48M Sell
198,535
-35,000
-15% -$376K 0.01% 567
2023
Q3
$2.2M Sell
233,535
-11,775
-5% -$124K 0.01% 546
2023
Q2
$2.52M Sell
245,310
-763
-0.3% -$6.95K 0.01% 529
2023
Q1
$2.12M Buy
246,073
+160,774
+188% +$1.5M 0.01% 565
2022
Q4
$798K Sell
85,299
-62,530
-42% -$546K 0.01% 713
2022
Q3
$1.15M Sell
147,829
-47,761
-24% -$458K 0.01% 682
2022
Q2
$2M Sell
195,590
-39,696
-17% -$471K 0.02% 599
2022
Q1
$3.13M Buy
235,286
+1,224
+0.5% +$16.1K 0.02% 516
2021
Q4
$3.32M Sell
234,062
-119,981
-34% -$1.94M 0.02% 510
2021
Q3
$5.92M Buy
+354,043
New +$6.55M 0.04% 400

Other funds holding SWI

Jacobs Levy Equity Management's SWI Position: Q3 2024 in Review

Jacobs Levy Equity Management sold out of SolarWinds Corporation Common Stock (SWI) in Q3 2024, closing a stake of 131,015 shares — an estimated $1.58M sold.

Jacobs Levy Equity Management first reported a position in SWI in Q3 2021 and held it in 12 quarters. The position peaked at $5.92M in Q3 2021. 189 funds tracked by Wall St. Rank hold SWI as of Q3 2024.

  • Jacobs Levy Equity Management reported no remaining SolarWinds Corporation Common Stock position as of Q3 2024 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 131,015 SolarWinds Corporation Common Stock shares in Q3 2024, an estimated $1.58M.
  • Jacobs Levy Equity Management first reported a position in SolarWinds Corporation Common Stock in Q3 2021 and held it in 12 quarters.
  • Jacobs Levy Equity Management's SolarWinds Corporation Common Stock position peaked at $5.92M in Q3 2021.
  • 189 funds tracked by Wall St. Rank held SolarWinds Corporation Common Stock as of Q3 2024.

Based on Jacobs Levy Equity Management's 13F filing for Q3 2024, filed 14 Nov 2024.